Case Study: How to ensure sterility in end-to-end bulk management?

micheal-eder

Michael Eder

June 18, 2020

Table of contents

Show

Sporadic product loss through cross contamination has made a global CMO (Contract Manufacturing Organization) reflect on their current operation system of  bulk drug substance management. The goal was to find a seamless and 100% sterile end-to-end system between downstream and fill & finish.

The implementation of a closed system was inevitable in order to guarantee sterility. So the CMO figured out that the combination of temperature resilient and radically simple sterile connectors together with the most robust and single use bag tailored protection thoughout its whole journey from filling, freezing, storing, shipping, thawing and draining was the best formula to ensure sterility.

The case study depicts how the implementation of Single Use Support and CPC products positively impacted on the performance of the company.

Case Study - Ensuring end to end sterility

How to ensure sterility in a -80° C closed system operation of end-to-end bulk management

For further information, have a listen to one of our podcast episodes:

micheal-eder

Michael Eder

Senior Marketing Manager

Michael Eder, MA, is Senior Marketing Manager at Single Use Support. He is expert in pharma and health communication with his 8+ years experience in pharma. After completing his master's degree in International Healthcare Management at MCI The Entrepreneurial school in Innsbruck, he has gained experience in the pharmaceutical field. Michael creates articles about Freeze Thaw applications and Platform solutions from Single Use Support and is the author of current news with Single Use Support worldwide. 

More from Michael Eder

Vaccines

The development process of biosimilars

The development process of biosimilars slightly differs from the one of their reference biologics. In this article, we will discuss each phase in detail.

micheal-eder

Michael Eder

May 13, 2024

Vaccines

Biomanufacturing: Process, steps and challenges in manufacturing biologics

As biologics have become a central pillar in today’s healthcare sector, their manufacturing process increasingly draws attention. In this article, we will discuss the process step by step, including challenges and possible ways to overcome them.

micheal-eder

Michael Eder

May 13, 2024

Read more about End-to-end Solution

End-to-end Solution

An introduction to therapeutic proteins

Therapeutic proteins hold promise in the treatment of numerous medical conditions, and progress in this field is far from being over. This is reason enough to take a general look at this class of therapeutics.

Alexander Fuchs | Single Use Support

Alexander Fuchs

April 10, 2024

End-to-end Solution

Protein storage: How to increase protein stability?

Prior to be used in diagnostics or therapeutics, proteins have to be safely stored. In this article, we will assess methods to preserve their stability upon storage.

Alexander Fuchs | Single Use Support

Alexander Fuchs

April 10, 2024

End-to-end Solution

Protein production and optimization strategies

Protein production is a crucial process that which a large variety of pharmaceutical products rely on. Therefore, we will discuss this procedure in this article, along with possibilities to improve it.


 

Khalil Essani - Single Use Support

Khalil Essani

April 9, 2024

End-to-end Solution

Protein stability – all you need to know

Protein stability is crucial to be maintained along the manufacturing process of protein-based products. In this article, we will discover what influences protein stability, along with methods to assess and increase it.

Khalil Essani - Single Use Support

Khalil Essani

April 9, 2024